Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-16 15:04:29 UTC |
---|
Update Date | 2022-03-07 02:49:09 UTC |
---|
HMDB ID | HMDB0001438 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 25-Hydroxyvitamin D2 |
---|
Description | 25-Hydroxyvitamin D2, also known as 25-hydroxycalciferol or ercalcidiol, belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. Based on a literature review very few articles have been published on 25-Hydroxyvitamin D2. |
---|
Structure | C[C@H](\C=C\[C@H](C)C(O)(C)C)C1CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C InChI=1S/C28H44O2/c1-19-10-14-24(29)18-23(19)13-12-22-8-7-17-28(6)25(15-16-26(22)28)20(2)9-11-21(3)27(4,5)30/h9,11-13,20-21,24-26,29-30H,1,7-8,10,14-18H2,2-6H3/b11-9+,22-12+,23-13-/t20-,21+,24+,25?,26+,28-/m1/s1 |
---|
Synonyms | Value | Source |
---|
25-Hydroxycalciferol | HMDB | 25-Hydroxyergocalciferol | HMDB | 25-Hydroxyvitamin D | HMDB | 9,10-Secoergosta-5,7,10(19),22-tetraene-3b,25-diol | HMDB | Ercalcidiol | HMDB | 25 Hydroxycalciferol | HMDB | 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol | HMDB | 25 Hydroxyvitamin D2 | HMDB | 25-Hydroxyvitamin D 2 | HMDB | 25 Hydroxyvitamin D 2 | HMDB | 25 Hydroxyergocalciferol | HMDB | 25-Hydroxyvitamin D2 | MeSH |
|
---|
Chemical Formula | C28H44O2 |
---|
Average Molecular Weight | 412.6478 |
---|
Monoisotopic Molecular Weight | 412.334130652 |
---|
IUPAC Name | (1S,3Z)-3-{2-[(3aS,4E,7aR)-1-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol |
---|
Traditional Name | 25-hydroxyvitamin D |
---|
CAS Registry Number | 21343-40-8 |
---|
SMILES | C[C@H](\C=C\[C@H](C)C(O)(C)C)C1CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C |
---|
InChI Identifier | InChI=1S/C28H44O2/c1-19-10-14-24(29)18-23(19)13-12-22-8-7-17-28(6)25(15-16-26(22)28)20(2)9-11-21(3)27(4,5)30/h9,11-13,20-21,24-26,29-30H,1,7-8,10,14-18H2,2-6H3/b11-9+,22-12+,23-13-/t20-,21+,24+,25?,26+,28-/m1/s1 |
---|
InChI Key | KJKIIUAXZGLUND-BJWBXCNSSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as vitamin d and derivatives. Vitamin D and derivatives are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Vitamin D and derivatives |
---|
Direct Parent | Vitamin D and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Triterpenoid
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
25-Hydroxyvitamin D2,1TMS,isomer #1 | C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O[Si](C)(C)C)CC[C@@H]12 | 3395.2 | Semi standard non polar | 33892256 | 25-Hydroxyvitamin D2,1TMS,isomer #2 | C=C1CC[C@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]12 | 3354.0 | Semi standard non polar | 33892256 | 25-Hydroxyvitamin D2,2TMS,isomer #1 | C=C1CC[C@H](O[Si](C)(C)C)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O[Si](C)(C)C)CC[C@@H]12 | 3397.3 | Semi standard non polar | 33892256 | 25-Hydroxyvitamin D2,1TBDMS,isomer #1 | C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3630.5 | Semi standard non polar | 33892256 | 25-Hydroxyvitamin D2,1TBDMS,isomer #2 | C=C1CC[C@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]12 | 3578.5 | Semi standard non polar | 33892256 | 25-Hydroxyvitamin D2,2TBDMS,isomer #1 | C=C1CC[C@H](O[Si](C)(C)C(C)(C)C)C/C1=C/C=C1\CCC[C@]2(C)C([C@H](C)/C=C/[C@H](C)C(C)(C)O[Si](C)(C)C(C)(C)C)CC[C@@H]12 | 3865.7 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 25-Hydroxyvitamin D2 GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4j-3019000000-36465aa35c47ab80eef3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 25-Hydroxyvitamin D2 GC-MS (2 TMS) - 70eV, Positive | splash10-000x-1603390000-821c6f61bded227ff271 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 25-Hydroxyvitamin D2 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 25-Hydroxyvitamin D2 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 10V, Positive-QTOF | splash10-01ot-0119200000-6a31a4086362269024cd | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 20V, Positive-QTOF | splash10-0a6s-0459000000-45ba752a30c854da68cc | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 40V, Positive-QTOF | splash10-0fj4-6395000000-2a0bb52b37082e56a80e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 10V, Negative-QTOF | splash10-03di-0005900000-3e4d6f3ace31e3d64321 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 20V, Negative-QTOF | splash10-03dl-1009500000-7f5a0d3322017b58bde3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 40V, Negative-QTOF | splash10-000i-9208000000-069f4c813e56ffb20663 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 10V, Negative-QTOF | splash10-03di-0002900000-39eecae8f9fc743e5708 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 20V, Negative-QTOF | splash10-03dl-1109800000-22189a4f31317c5db455 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 40V, Negative-QTOF | splash10-056r-1119100000-5892af2e237af403d25d | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 10V, Positive-QTOF | splash10-022a-0493100000-dbc8fa812c52d77c3d89 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 20V, Positive-QTOF | splash10-0v4r-2193000000-6d9019ed5e8ff95fdb96 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 25-Hydroxyvitamin D2 40V, Positive-QTOF | splash10-014i-6971000000-63c804a7bc1e0f9a9f35 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
Disease References | Anephric patients |
---|
- Shepard RM, Horst RL, Hamstra AJ, DeLuca HF: Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55-69. [PubMed:227368 ]
| Smith-Lemli-Opitz syndrome |
---|
- Rossi M, Federico G, Corso G, Parenti G, Battagliese A, Frascogna AR, Della Casa R, Dello Russo A, Strisciuglio P, Saggese G, Andria G: Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2005;28(1):69-80. [PubMed:15702407 ]
| Hyperphosphatasia |
---|
- Saki F, Karamizadeh Z, Nasirabadi S, Mumm S, McAlister WH, Whyte MP: Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. J Bone Miner Res. 2013 Jun;28(6):1501-8. doi: 10.1002/jbmr.1868. [PubMed:23322328 ]
| Nephrotic syndrome |
---|
- Sato KA, Gray RW, Lemann J Jr: Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med. 1982 Mar;99(3):325-30. [PubMed:6977006 ]
|
|
---|
General References | - Shepard RM, Horst RL, Hamstra AJ, DeLuca HF: Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55-69. [PubMed:227368 ]
- Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Drager A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, Prlic A, Sastry A, Danielsdottir AD, Heinken A, Noronha A, Rose PW, Burley SK, Fleming RMT, Nielsen J, Thiele I, Palsson BO: Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat Biotechnol. 2018 Mar;36(3):272-281. doi: 10.1038/nbt.4072. Epub 2018 Feb 19. [PubMed:29457794 ]
|
---|